Publisher
Springer Science and Business Media LLC
Reference76 articles.
1. Fenaux P, Haase D, Sanz GF, et al. Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii57–69.
2. Gidaro A, Deliliers GL, Gallipoli P, et al. Laboratory and clinical assessments to treat myelodyplastic syndromes. Clin Chem Lab Med. 2016;. doi: 10.1515/cclm-2015-0789 .
3. Fey MF, Buske C, on behalf of the ESMO Guidelines Working Group. Acute myelodysplastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi138–43.
4. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukaemia: rationale and important changes. Blood Cancer J. 2009;114(5):937–51.
5. Greenberg P, Cox C, LeBeau MM, et al. International Scoring System for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079–88.
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献